Several clinicopathological characteristics, including age at diagnosis, tumor location, and patient survival, differ between patients with MLH1-deficient/BRAF-V600E–mutated dMMR CRC and those with MLH1-deficient/BRAF wild-type dMMR CRC (70, 71). The gene discussed is MLH1; the disease is neoplasm.